Need Help?

scRNA-seq of total bone marrow mononuclear cells and CD3+ T cells of multiple myeloma patients and healthy donors

The study includes 50 scRNA-seq samples of bone marrow aspirates of 11 multiple myeloma patients and 3 healthy donors generated with the 10x Genomics platform (Chromium Single Cell 3’ Solution v2). For the multiple myeloma patients, paired longitudinal samples are available from initial diagnosis and long-term surivor state. For each patient and timepoint, total bone marrow mononuclear cells and CD3+ T cells have been sequenced separately.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001010025 Illumina HiSeq 4000 Illumina NovaSeq 6000 82
Publications Citations
Proteomic signatures improve risk prediction for common and rare diseases.
Nat Med 30: 2024 2489-2498
4
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.
Nat Commun 15: 2024 10396
0